AHSCT resets the immune system in highly active RRMS after high-efficacy drugs fail, delivering higher NEDA, fewer relapses, and durable function gains. When high-efficacy drugs stop holding relapsing ...
Patients with cancer frequently receive broad-spectrum antibiotics, even if they are at low risk for antimicrobial-resistant infections.A computer prompt that notifies clinicians that a patient would ...
Adults living with Alzheimer’s-related dementia now have a second FDA-approved drug for agitation, and for the first time, ...
The safety performance of autonomous vehicle (AV) algorithms is boosted by 90% using simulation data that better incorporates ...
Cancer therapy has dramatically changed over the past many decades, not only in efficacy but also complexity, with targeted ...